Electronic Health Record (EHR)-Based Intervention for Gastroesophageal Reflux Disease (GERD) and Chronic Non-steroidal Anti-inflammatory Drug (NSAID) Use

AstraZeneca

Status: Completed

Conditions: GERD

Study type: Observational

Funder types: Industry

Identifiers

NCT00691171

NIS-GUS-DUM-2007/1

Details and patient eligibility

About

The purpose of the study is to examine the impact of augmented, high-quality physician-coordinated care executed via an electronic health record (EHR)-based intervention on quality of care for gastroesophageal reflux disease (GERD) and for gastroprotection for patients on chronic non-steroidal anti-inflammatory drugs (NSAIDs) at increased risk for upper GI tract ulcers and ulcer related complications.

Enrollment: 5,234 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Eligibility as determined by criteria for participation in studies as part of the MQIC
• Agreement of participating clinical practices to undergo training in the electronic health record (EHR) intervention designed for this study

Exclusion criteria

• Based on voluntary participation by MQIC practices, so practices were excluded if they decided to opt out

Trial design

5,234 participants in 3 patient groups

1

Description:

GERD: Patients with established diagnoses of GERD based on ICD-9 codes

2

Description:

Atypical GERD: Patients without an established diagnosis of GERD with atypical symptoms that could be due to GERD (e.g., asthma)

3

Description:

Chronic NSAID users: Patients using chronic NSAIDs who are at increased risk of GI complications (defined as previous diagnosis of peptic ulcer disease; age 75 or older; or concomitant use of corticosteroids, anticoagulants, or aspirin)